openPR Logo
Press release

Global Immune-Mediated Inflammatory Diseases Treatment Market Trends, Size, Competitive Analysis and Forecast 2019-2025

06-21-2021 12:15 PM CET | Health & Medicine

Press release from: Orion Market Research

Global Immune-Mediated Inflammatory Diseases Treatment

The global immune-mediated inflammatory disease treatment market is anticipated to grow at a CAGR of over 6% during the forecast period. Immune-mediated inflammatory disease treatment has been improved significantly over the past years due to the development of a series of targeted biological therapies and novel therapies in the market. Currently, quite a lot of research is going on in the field regarding the treatment of immune-mediated disease. In addition, new drugs and treatment options are entering the market, which is fuelling the growth of the global immune-mediated inflammatory disease treatment market. For instance, in August 2019, the US FDA approved upadacitinib (Rinvoq), an oral medication for adults with moderate to severe rheumatoid arthritis that is not being well-controlled by methotrexate.

To Request a Sample of our Report on Global Immune-Mediated Inflammatory Diseases Treatment Market: https://www.omrglobal.com/request-sample/immune-mediated-inflammatory-diseases-treatment-market

However, the late diagnosis of immune-mediated inflammatory disease coupled with challenges during the treatment such as slow or incomplete healing is limiting the growth of the global immune-mediated inflammatory disease treatment market. In addition, the high cost associated with the treatment also restricts the global immune-mediated inflammatory disease treatment market growth. For instance, due to their high costs, considerable differences in the utilization of treatment options exist across the globe. Various European countries are restricting access despite professional society guideline recommendations. Additionally, the adoption of biologic therapies for the treatment by healthcare providers has been particularly poor in many Central and Eastern European countries which are affecting the growth of immune-mediated inflammatory diseases. Moreover, the presence of a small patient base for rare disease coupled with disproportion in the availability of treatments and resources to manage patients, and train experts in developing economies will also limit the growth of the global immune-mediated inflammatory diseases treatment market.

(Get 15% Discount on Buying this Report)
A full Report of Global Immune-Mediated Inflammatory Diseases Treatment Market is Available at: https://www.omrglobal.com/industry-reports/immune-mediated-inflammatory-diseases-treatment-market

Global Immune-Mediated Inflammatory Diseases Treatment Market Segmentation

By Disease Type
• Multiple Sclerosis
• Psoriasis
• Inflammatory Bowel Disease
• Rheumatoid Arthritis
• Others

By Drug Class

• Anti- Inflammatory Biologics
• Non- Steroidal Anti- Inflammatory Drugs
• Corticosteroids

By Treatment Type
• Targeted Biologic Therapies
• Novel Therapies

Regional Analysis

North America
• United States
• Canada

Europe
• UK
• Germany
• Spain
• France
• Italy
• Rest of Europe

Asia-Pacific
• India
• China
• Japan
• Rest of APAC
Rest of The World

Company Profiles
• Abbvie Inc.
• Abivax SA
• AstraZeneca PLC
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Co.
• Celgene Corp.
• Daiichi Sankyo Co., Ltd.
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences, Inc.
• GlaxoSmithKline PLC
• Innovate Biopharmaceuticals Inc.
• Johnson & Johnson Services Inc.
• LG Chem Ltd.
• Merck & Co., Inc.
• Merck KGaA
• Novartis International AG
• Pharmaxis Ltd.
• Sanofi S.A.
• UCB S.A.
• Ventria Bioscience Inc.

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/immune-mediated-inflammatory-diseases-treatment-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Immune-Mediated Inflammatory Diseases Treatment Market Trends, Size, Competitive Analysis and Forecast 2019-2025 here

News-ID: 2309735 • Views: 91

More Releases from Orion Market Research

Urology Devices Market 2021 Size, Growth Analysis Report, Forecast to 2027
The global urology devices market is anticipated to grow at a CAGR of around 5.1% during the forecast period (2021-2027). The key factors to drive the market growth include the increasing prevalence of chronic kidney diseases that may lead to end-stage kidney or renal disease (ESRD). According to a 2019 report by the Centres for Disease Control and Prevention (CDC), 15% of adults in the US, or approximately 37 million
Tea and Tea Based Beverages Market: Size & Trends Shows a Rapid Growth by 2027
The global tea and tea-based beverages market is anticipated to grow at a significant CAGR during the forecast period. Tea and tea-based beverages are aromatic beverages made by infusing tea leaves, also known as Camellia sinensis, a native herb of Eastern Asia. Tea and tea-based beverages have been gaining significant popularity for the past long years. Owing to its numerous health benefits, including a boost in endurance, reducing the risk
Solar Battery Market 2021 Growth, COVID Impact, Trends Analysis Report 2027
The global solar battery market is anticipated to grow at a CAGR of around 15.5% during the forecast period (2021-2027). The key factors to drive the market growth include increasing demand for sustainable energy storage solutions as the government of various countries are promoting clean energy and sustainable energy sources, therefore the demand for solar power batteries is projected to increase over the forecast period. For instance, in June 2021,
Protein Crystallization Market 2021 Growth, COVID Impact, Trends Analysis Report …
The global protein crystallization Market system market is anticipated to grow at a considerable CAGR of 8.9% during the forecast period (2021-2027). The key factor to drive the market growth is the increasing rate of advanced research activities and experiments wherein researchers are taking protein crystallization up to space. These advanced researches are on important health issues faced by people in various countries. For instance, according to the ISS National

All 5 Releases


More Releases for Inflammatory

Digital Landscape: Inflammatory Bowel Disease Market
The Digital Landscape Inflammatory Bowel Disease market report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn’s disease and ulcerative colitis (UC). Key Highlights - US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly branded, unbranded and mobile app. Janssen was the most active competitor in the branded and social media spaces in 2017. Branded activity also seen from pipeline
Pelvic Inflammatory Disease Market - Positive long-term growth outlook 2025
Pelvic inflammatory disease is an infection in the female reproductive system that includes ovaries, fallopian tubes, uterus, and cervix. Pelvic inflammation is generally caused by a sexually transmitted infection, like gonorrhea and chlamydia. Between 10% to 20% of women with gonococcal infection and 20% to 40% of women with cervical chlamydial infection eventually develop pelvic inflammatory disease. Early diagnosis and treatment are believed to be key elements in the prevention
Chronic Inflammatory Demyelinating Polyneuropathy Treatment Market Outlook to 20 …
Chronic inflammatory demyelinating polyneuropathy (CIPD) is an autoimmune disorder of the peripheral nervous system characterized by the weakness and impaired sensory function in the arms and legs. This disorder is caused by damage to the myelin sheath, a fatty covering that wraps and protects nerve fibers. The nerves stimulate muscle contraction and transmit sensory information to the brain through electrical impulses. Myelin acts as an insulation and allows efficient flow
Global Anti-inflammatory Therapeutics Industry Market Research Report 2017
Summary The Global Anti-inflammatory Therapeutics Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Anti-inflammatory Therapeutics industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Anti-inflammatory Therapeutics market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as
Research Offers 10-Year Forecast on Inflammatory Diseases Market
A new understanding of inflammatory diseases has changed the drug development landscape for several major diseases that are affecting millions of people in the world. Inflammation describes the primary response of the body that eliminates the cause of injury. Periodically, body’s defense mechanism works inappropriately that leads to inflammation. Drug development has focused on treating each disease symptoms separately. The discovery of drugs to treat inflammatory diseases related with immune
Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) Treatment Market
Chronic inflammatory demyelinating polyneuropathy (CIPD) is an autoimmune disorder of the peripheral nervous system characterized by the weakness and impaired sensory function in the arms and legs. This disorder is caused by damage to the myelin sheath, a fatty covering that wraps and protects nerve fibers. The nerves stimulate muscle contraction and transmit sensory information to the brain through electrical impulses. Myelin acts as an insulation and allows efficient flow